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necessary or useful duplicates (Kellis et 
al., 2004; Wapinski et al., 2007; DeLuna 
et al., 2008) with concomitant elimina-
tion of excess genetic baggage (Torres 
et al., 2008). Besides providing an inter-
esting snapshot of microbial evolution, 
these results are also relevant to cancer, 
as many tumors exhibit polyploidy and 
aneuploidy, reflecting a similar case of 
microevolution (Ganem et al., 2007).
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The zonula adherens (ZA) is a specialized cadherin-based structure found at the contacts between 
epithelial cells. Meng et al. (2008) now identify a protein complex containing the microtubule minus-
end-binding protein Nezha, which provides a critical link between microtubules and cadherins in 
ZA biogenesis and maintenance.Classical cadherin adhesion receptors 
play critical roles in tissue organization. 
They mediate cell-cell recognition and 
morphogenesis during development 
and support cohesion in established 
tissues. Cadherin dysfunction can have 
detrimental effects such as promoting 
the metastasis of epithelial cancers. 
The diverse morphogenetic roles of 
cadherin receptors are not due solely 
to their intrinsic adhesive properties but 
also depend on the crosstalk between 
cadherins and key elements of the cyto-
plasmic machinery involved in signal 
transduction, membrane trafficking, and 
cytoskeletal organization. Although cad-
herins have long been thought to coop-
erate with the actin cytoskeleton, less 
attention has been paid to their capacity 
to interact with microtubules. Report-ing in this issue, Meng et al. (2008) now 
identify a new cadherin-based protein 
complex in mammalian epithelial cells 
that can anchor microtubule minus ends 
to the zonula adherens (ZA) and is nec-
essary for the biogenesis of this special-
ized junction.
Cadherins localize at epithelial cell-cell 
contacts in two patterns: the first com-
prises clusters and strands distributed 
throughout the lateral interface, and the 
second consists of an apically located 
linear band that is thought to mark the 
ZA, a specialized cell-cell junction 
(Kametani and Takeichi, 2007). As little 
is known about how the ZA is generated 
and maintained, Meng and colleagues 
set out to identify new regulators of the 
ZA in mammalian cells by searching 
for proteins that bind to the cadherin-Cell 135, Nassociated protein p120-catenin. They 
uncover a new interacting partner, a 
pleckstrin homology (PH) domain protein 
of unknown function called PLEKHA7 
(PH domain-containing family A, mem-
ber 7). Immunoprecipitation analysis 
reveals that PLEKHA7 interacts with the 
E-cadherin-catenin complex. PLEKHA7 
specifically colocalizes with the pool of 
E-cadherin at the ZA in a p120-depen-
dent manner. When p120 was depleted 
from the cells, or when binding of E-cad-
herin to p120 was disrupted by mutation, 
PLEKHA7 was no longer found at the cell 
junctions. Importantly, Meng et al. report 
that PLEKHA7 expression is needed for 
the maintenance of ZA integrity. Specifi-
cally, PLEKHA7 appears to promote the 
incorporation of cadherin clusters into 
the higher-order structure of the ZA.ovember 28, 2008 ©2008 Elsevier Inc. 791
figure 1. A complex of nezha and PlekHA7 links microtubules with cadherins at Junc-
tions between epithelial cells
p120-catenin recruits Nezha and PLEKHA7 to the E-cadherin/β-catenin complex at the zonula adherens 
(ZA). Nezha binds to microtubules at their minus ends and, together with the microtubule minus-end-
directed motor KIFC3, supports the organization of cadherin clusters into the ZA.The authors further identify another 
poorly characterized protein, which 
they call Nezha (formerly KIAA1543), as 
a binding partner of PLEKHA7. Deple-
tion of Nezha from cultured human cells 
disrupted the ZA, implying that Nezha 
might mediate the impact of PLEKHA7 
on the biogenesis of the ZA. Indeed, 
localization of Nezha to the ZA is per-
turbed when PLEKHA7 is absent. Inter-
estingly, Nezha is only found at the ZA at 
late stages of junction maturation, after 
PLEKHA7 is already in place. Although 
PLEKHA7 appears to be necessary to 
recruit Nezha into the ZA, the associa-
tion between these two proteins is likely 
to be highly regulated.
During their characterization of Nezha, 
the authors make the surprising obser-
vation that it is a microtubule minus-
end-binding protein. Microtubules are 
polarized polymers whose ends possess 
distinct dynamic properties. Microtubule 
plus ends serve as sites of polymeriza-
tion; they are highly dynamic and associ-
ate with a large number of cellular factors 
(Akhmanova and Steinmetz, 2008). The 
minus ends, on the other hand, serve as 
sites of microtubule anchoring or dis-
assembly, and only a few proteins are 
known to specifically interact with them 
(Dammerman et al., 2003). The authors 
find that endogenous Nezha localizes 
to the minus ends of noncentrosomal 
microtubules in vivo and confirm that this 
protein binds to the minus ends of micro-
tubules in vitro. Time-lapse microscopy 792 Cell 135, November 28, 2008 ©2008 Elsof live cultured human cells reveals that 
Nezha-containing foci at cell-cell con-
tacts appear to serve as sites of microtu-
bule outgrowth and anchoring. Further, 
depolymerization of microtubules with 
nocodazole ultimately causes the ZA 
to fragment. This suggests an attrac-
tive model whereby the cadherin-based 
Nezha/PLEKHA7 complex supports ZA 
biogenesis by anchoring microtubules 
at their minus ends (Figure 1). Obtaining 
definitive proof for this model will require 
evidence that a significant population of 
microtubules is anchored by their minus 
ends at the ZA, which remains a chal-
lenge due to the high density of three-
dimensional microtubule networks in dif-
ferentiated epithelial cells.
How might a minus-end-anchoring 
apparatus contribute to the biogenesis of 
the ZA? An important property of micro-
tubule polarity is to provide directional 
tracks for motor-dependent transport 
of macromolecules and membranes. 
Indeed, the contribution of microtubules 
to cell-cell junctions has often been 
framed in terms of membrane transport. 
Consistent with this, Meng et al. report 
that kinesin-14/KIFC3, the minus-end-
directed motor previously implicated in 
apical membrane transport in epithelial 
cells (Noda et al., 2001), is required for 
ZA integrity. It is tempting to specu-
late that Nezha-mediated anchorage of 
microtubule minus ends orients tracks 
for KIFC3-based delivery of molecules 
necessary for the biogenesis and main-evier Inc.tenance of the ZA. However, the exact 
nature of the potential cargo remains 
to be determined. Interestingly, KIFC3 
itself localizes to the ZA in a Nezha- and 
PLEKHA7-dependent fashion, suggest-
ing that it may play a structural or sig-
naling role or even participate in micro-
tubule organization at epithelial cell-cell 
junctions.
Irrespective of the underlying mecha-
nism, characterization of Nezha and 
PLEKHA7 function emphasizes the 
importance of protein cooperativity in 
ZA biogenesis. Although PLEKHA7 is 
necessary to recruit Nezha into junc-
tions, depletion of Nezha also causes 
PLEKHA7 to be lost from junctions. Thus, 
the incorporation of Nezha appears to 
stabilize PLEKHA7, either directly or 
indirectly. Similarly, microtubule depo-
lymerization leads to the eventual loss of 
KIFC3 and Nezha and disruption of the 
ZA itself. This implies that the ZA, rather 
than being a static structure, is dynamic. 
Such cooperativity is likely to extend to 
other signaling and cytoskeletal interac-
tions at the ZA.
The findings of Meng et al. add to a 
growing body of evidence linking cad-
herins and microtubules. Microtubule 
disruption by overall depolymerization 
or by freezing the dynamic activity of 
the plus ends can perturb cadherin-
based cell-cell contacts (Stehbens et 
al., 2006; Waterman-Storer et al., 2000). 
Furthermore, other studies provide evi-
dence that the dynamic plus ends of 
microtubules can also extend into cad-
herin-based junctions. Microtubules in 
fibroblasts and isolated epithelial cells 
are often organized as arrays with their 
minus ends anchored at centrosomes 
and plus ends facing the cell periphery. 
However, relocation of microtubule minus 
ends from the centrosomes to either the 
apical surface or to cell-cell contacts 
often occurs during epithelial biogenesis 
and is a process that depends on the 
microtubule minus-end-anchoring factor 
ninein (Dammerman et al., 2003; Lechler 
and Fuchs, 2007). Interestingly, Meng 
and colleagues report that Nezha does 
not colocalize with ninein, and, unlike 
PLEKHA7 and ninein, it does not bind 
to centrosomes. This observation will 
require further investigation to elucidate 
its place in the regulation of microtubule 
minus ends.
Most importantly, this new study sheds 
light on the enigmatic biology of the ZA. 
This distinctive structure, first character-
ized by electron microscopy (Farquhar 
and Palade, 1963), is thought to be a 
higher-order molecular apparatus built 
on a cadherin core that also includes 
many other membrane proteins such as 
noncadherin adhesion molecules (Gum-
biner, 2005). The observation by Meng 
et al. that Nezha, PLEKHA7, and KIFC3 
appear to promote the accumulation of 
cadherin in the ZA at the expense of the 
cadherin pool at the cell’s lateral con-
tacts further supports the notion that the 
ZA represents a higher-order organiza-
tion of cadherins at cell-cell junctions. 
Many functions have been suggested for 
the ZA beyond basic cadherin adhesion, Because of heightened genomic insta-
bility, cancer cells often have a complex 
karyotype with many gains and losses in 
gene copy number. Although compara-
tive genome hybridization (CGH) tech-
nologies now enable the mapping of 
copy number gain or loss at high resolu-
tion, the genomic regions pinpointed in 
such studies are still quite large and may 
contain tens or even hundreds of genes. 
A key question that often remains to be 
answered is which of the many genes 
in these regions are the “drivers” of the 
oncogenic phenotype and which are 
“passengers” whose altered expression 
does not contribute to the genesis of the 
cancer. In an elegant study in this issue, 
Zender et al. (2008) describe an integra-
tive genomics approach to identify the 
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Of the myriad alterations in gene
for the cancer phenotype? In this
approach to identify new tumor including cell signaling, apical cell mor-
phogenesis, and adhesive stabilization. 
However, efforts to dissect these roles 
for the ZA have been hampered by a 
lack of strategies to specifically perturb 
ZA formation without affecting basic 
cadherin function. The identification of 
mechanisms that regulate epithelial cell 
junction organization by Meng et al. and 
others opens the way for future studies 
examining the specific cellular and tissue 
functions of the ZA.
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